Table 3.

Utilities for diagnosis-related health states, VAS and TTO methods

Health State	n	Visual Analog Score				Time Trade Off Score
		Median	Range	Mean	SD	Median	Range	Mean	SD
Ovarian cancer-clinical remission	16	0.75	0.32–1	0.72	0.21	0.95	0.03–0.97	0.83	0.25
Early ovarian cancer – newly diagnosed	16	0.67	0.24–0.94	0.62	0.19	0.93	0.03–0.97	0.81	0.26
Newly diagnosed ovarian cancer – chemotherapy/grade 1–2 toxicity	16	0.56	0.22–0.86	0.50	0.21	0.67	0.03–0.97	0.60	0.31
Recurrent ovarian cancer – responding to chemotherapy/grade 3–4 toxicity	14	0.39	0.17–0.91	0.40	0.19	0.67	0.17–0.97	0.61	0.24
Recurrent ovarian cancer – responding to chemotherapy/grade 1–2 toxicity	15	0.43	0.22–0.89	0.44	0.20	0.50	0.03–0.93	0.50	0.34
Advanced ovarian cancer – newly diagnosed	14	0.41	0.15–0.85	0.45	0.23	0.50	0.03–0.93	0.55	0.29
Newly diagnosed ovarian cancer – chemotherapy/grade 3–4 toxicity	15	0.39	0.06–0.9	0.37	0.22	0.50	0.03–0.97	0.49	0.36
Recurrent ovarian cancer – progressive/grade 3–4 toxicity	15	0.17	0.05–0.92	0.27	0.23	0.50	0.03–0.93	0.47	0.34
Recurrent ovarian cancer – progressive/grade 1–2 toxicity	16	0.37	0.02–0.80	0.36	0.20	0.42	0.03–0.93	0.40	0.33
End stage ovarian cancer	15	0.08	0.01–1	0.16	0.25	0.03	0.03–0.83	0.16	0.25